Application 103976

Type
BLA
Sponsor
GENENTECH

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103976Xolairomalizumab351(a)Rx2026-07-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001XOLAIROMALIZUMABVIAL150MG/VIALNoNo
002XOLAIROMALIZUMABSYRINGE75MG/0.5MLNoNo
003XOLAIROMALIZUMABSYRINGE150MG/MLNoNo
004XOLAIROMALIZUMABSYRINGE300MG/2MLNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XOLAIROMALIZUMABGenentech, Inc.7f6a2191-adfb-48b9-9bfa-0d9920479f0d2025-12-02Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA103976
ndc (product): 50242-214
ndc (product): 50242-040
ndc (product): 50242-215

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 24 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50242-040XOLAIRomalizumabGenentech, Inc.BLACurrent
50242-040XOLAIRomalizumabGenentech, Inc.BLACurrent
50242-040XOLAIRomalizumabGenentech, Inc.BLACurrent
50242-040XOLAIRomalizumabGenentech, Inc.BLACurrent
50242-040XOLAIRomalizumabGenentech, Inc.BLACurrent
50242-040XOLAIRomalizumabGenentech, Inc.BLACurrent
50242-040XOLAIRomalizumabGenentech, Inc.BLACurrent
50242-040XOLAIRomalizumabGenentech, Inc.BLACurrent
50242-214Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-214Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-214Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-214Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-214Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-214Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-214Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-214Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-215Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-215Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-215Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-215Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-215Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-215Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-215Xolair PFSomalizumabGenentech, Inc.BLACurrent
50242-215Xolair PFSomalizumabGenentech, Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77574SUPPL 2024-02-20
77512SUPPL 2024-02-16
77511SUPPL 2024-02-16
76584SUPPL 2023-11-16
74164SUPPL 2023-05-03
73806SUPPL 2023-03-20
70561SUPPL2022-03-18
70560SUPPL2022-03-18
70559SUPPL2022-03-18
67031SUPPL2021-04-13
67022SUPPL2021-04-12
67021SUPPL2021-04-12
65849SUPPL2021-01-07
65848SUPPL2021-01-07
65468SUPPL2020-12-02
65445SUPPL2020-12-01
65444SUPPL2020-12-01
58530SUPPL2019-05-02
58529SUPPL2019-05-02
58524SUPPL2019-05-02
55798SUPPL2018-10-03
55768SUPPL2018-10-01
18723SUPPL2016-07-08
9531SUPPL2016-07-07
39773SUPPL2015-12-08
9530SUPPL2015-12-08
9529SUPPL2014-10-01
39772SUPPL2014-09-30
31759SUPPL2014-03-25
18722SUPPL2014-03-25
31758SUPPL2012-01-05
31757SUPPL2011-01-10
31756SUPPL2010-02-05
18721SUPPL2007-07-02
31755SUPPL2006-04-14
18720SUPPL2006-04-14
44424ORIG2004-03-30
18719ORIG2004-03-30
9528ORIG2004-03-30
68909ORIG1900-01-01
68908ORIG1900-01-01
68907ORIG1900-01-01
68906ORIG1900-01-01
68905ORIG1900-01-01
68904ORIG1900-01-01
68903ORIG1900-01-01
64995ORIG1900-01-01
63188ORIG1900-01-01
63187ORIG1900-01-01
63186ORIG1900-01-01
51624SUPPL1900-01-01
51623SUPPL1900-01-01
51622SUPPL1900-01-01
51621ORIG1900-01-01
51620ORIG1900-01-01
51619ORIG1900-01-01